By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Tricyclic antidepressant > Doxepin

Doxepin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|695 words

Doxepin Drug Profile

What is Doxepin?

Doxepin is a tricyclic antidepressant (TCA) medication that has been used for decades to treat various mental health and sleep disorders. Originally developed as an antidepressant, it is now commonly prescribed in lower doses for chronic insomnia due to its strong sedating properties. The medication affects multiple neurotransmitter systems in the brain to help improve mood and promote sleep.

Uses

Doxepin is approved and commonly used for several conditions:

  • Major depressive disorder: At higher doses (75-300mg), doxepin helps treat symptoms of depression by balancing brain chemicals that affect mood.
  • Chronic insomnia: Low-dose doxepin (3-6mg) is FDA-approved specifically for sleep maintenance insomnia, helping people stay asleep through the night.
  • Anxiety disorders: The medication can help reduce anxiety symptoms, particularly when they occur alongside depression.
  • Chronic pain conditions: Some healthcare providers prescribe doxepin off-label for fibromyalgia, neuropathic pain, and other chronic pain syndromes.
  • Dermatological conditions: Topical doxepin cream is used to treat severe itching associated with eczema and other skin conditions.

How it works

Doxepin works by blocking the reuptake of neurotransmitters serotonin and norepinephrine in the brain, allowing these mood-regulating chemicals to remain active longer. For sleep disorders, its primary mechanism involves blocking histamine H1 receptors, which promotes drowsiness and helps maintain sleep throughout the night. The medication also affects other receptor systems, including alpha-adrenergic and muscarinic receptors, which contribute to both its therapeutic effects and side effect profile.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and sedation
  • Dry mouth
  • Constipation
  • Blurred vision
  • Weight gain
  • Dizziness or lightheadedness
  • Urinary retention
  • Morning grogginess (with sleep formulations)

Serious side effects requiring immediate medical attention:

  • Irregular heartbeat or chest pain
  • Severe allergic reactions with difficulty breathing
  • Seizures
  • Suicidal thoughts or behavior, especially in young adults
  • Severe confusion or hallucinations

Warnings and precautions

  • Black box warning: All tricyclic antidepressants carry an FDA black box warning for increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults under 25.
  • Cardiovascular risks: Patients with heart disease, irregular heartbeat, or recent heart attack should use doxepin with extreme caution due to potential cardiac effects.
  • Pregnancy and breastfeeding: Doxepin is classified as pregnancy category C, meaning risks cannot be ruled out. The medication passes into breast milk and may affect nursing infants.
  • Elderly patients: Older adults are more sensitive to anticholinergic effects and may experience increased confusion, falls, and cognitive impairment.
  • Liver and kidney function: Patients with impaired liver or kidney function may require dose adjustments as the medication is processed through these organs.

Interactions

Doxepin has numerous important drug interactions:

  • MAO inhibitors: Can cause dangerous, potentially fatal interactions and should not be used within 14 days of each other.
  • Central nervous system depressants: Alcohol, benzodiazepines, and opioids can increase sedation and respiratory depression risk.
  • Anticholinergic medications: Antihistamines, certain bladder medications, and antipsychotics can amplify side effects like dry mouth and confusion.
  • Blood thinners: Warfarin and other anticoagulants may have altered effectiveness when combined with doxepin.
  • Heart medications: Antiarrhythmic drugs and some blood pressure medications can interact dangerously with doxepin’s cardiac effects.
  • Thyroid hormones: Can increase the risk of heart rhythm problems when combined with tricyclic antidepressants.
  • Cimetidine: This heartburn medication can increase doxepin levels in the blood, potentially causing toxicity.
  • St. John’s Wort: This herbal supplement may reduce doxepin’s effectiveness and increase side effects.

Check interactions with the GMJ Interaction Checker

Dosage

Doxepin dosing varies significantly based on the condition being treated:

  • Depression and anxiety: Starting dose is typically 25-75mg daily, gradually increased to 75-150mg daily. Maximum doses may reach 300mg daily in severe cases.
  • Insomnia: Low-dose formulations of 3mg or 6mg are taken 30 minutes before bedtime.
  • Elderly patients: Lower starting doses are recommended, often beginning at 10-25mg daily for depression or 3mg for sleep.

Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and other medical factors. Never adjust doses without medical supervision, as sudden changes can cause withdrawal symptoms or adverse effects.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Doxepin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/doxepin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised…

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial in Gender-Questioning Children

The UK has set a minimum age of 11 years for children…

Why Women Choose Freebirth: What Research Reveals About Unattended Childbirth

A growing number of women are choosing unattended childbirth, driven by desire…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Desipramine

By
Prof. Giorgi Pkhakadze
02/06/2026

Imipramine

By
Prof. Giorgi Pkhakadze
02/06/2026

Clomipramine

By
Prof. Giorgi Pkhakadze
02/06/2026

Nortriptyline

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up